Lycium barbarum polysaccharides attenuate kidney injury in septic rats by regulating Keap1-Nrf2/ARE pathway
Autor: | Qi Wu, Lantao Liu, Su-fen Guo, Xue-yong Wang, Tao Zhan, Huizhe Zheng, Zhifang Lang, Xiang-hui Meng, Hongwei Wang, Bin Yan |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine NF-E2-Related Factor 2 medicine.medical_treatment Blotting Western Intraperitoneal injection Inflammation Pharmacology Real-Time Polymerase Chain Reaction 030226 pharmacology & pharmacy General Biochemistry Genetics and Molecular Biology Rats Sprague-Dawley Sepsis 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Western blot health services administration medicine Animals General Pharmacology Toxicology and Pharmaceutics Kidney Kelch-Like ECH-Associated Protein 1 medicine.diagnostic_test biology business.industry pathological conditions signs and symptoms General Medicine Acute Kidney Injury medicine.disease biology.organism_classification Ulinastatin KEAP1 Antioxidant Response Elements Rats nervous system diseases body regions Disease Models Animal 030104 developmental biology medicine.anatomical_structure chemistry Cytokines population characteristics Lycium medicine.symptom business Drugs Chinese Herbal Signal Transduction |
Zdroj: | Life Sciences. 242:117240 |
ISSN: | 0024-3205 |
DOI: | 10.1016/j.lfs.2019.117240 |
Popis: | Lycium barbarum polysaccharides (LBP) are derived from Wolfberry and have antioxidant activities. This study aimed to evaluate the efficacy of LBP for kidney injury in a rat model of sepsis. Male rats were divided randomly to control group (Con), LPS group (LPS), ulinastatin group (ULI), low dose LBP group (LBP-1), middle dose LBP group (LBP-2) and high dose LBP group (LBP-3). After intraperitoneal injection of LPS (5 mg/kg) to make sepsis model (LPS group), 10,000 U/kg ulinastatin were given in ULI group, and 200, 400 and 800 mg/kg LBP was given in LBP-1, -2, -3 group, respectively. Serum IL-1β, IL-6, IL-8, TNF-α and NF-κB levels were measured by ELISA. Nrf2, Keap1, NF-κB, HO-1 and NQO1 expression levels were detected by PCR and Western blot analysis. We found that LBP decreased the levels of NF-κB and pro-inflammatory cytokines while attenuated kidney injury. In addition, LBP regulated Keap1-Nrf2/ARE signaling pathway in the kidney. In conclusion, LBP attenuates inflammation injury in the kidney via possible regulation of Keap1-Nrf2/ARE signaling. |
Databáze: | OpenAIRE |
Externí odkaz: |